Best Practices for Analysis of IVT mRNA using the Agilent Fragment Analyzer Systems

Facebook

Email

October 23, 2023

Quality control (QC) analysis is vital in in vitro transcription (IVT) mRNA workflows, as it minimizes risk during process development and production. This technical overview shows how the Agilent Fragment Analyzer systems can be used in the QC process of an mRNA vaccine development workflow, including the ability of the systems to accurately assess IVT mRNA sizing, resolution, and percent purity. Download this resource now to learn more.

Oops! It looks like there were some errors.

Please check the highlighted fields and try again.

Download Now

login

Name *
Company/Institution *
Institution Type *
Address *
Email Address *
Work Phone Number *
Are you planning to purchase any lab products related to this content? *
I would like to be contacted by an Agilent representative by telephone or email *
Yes
No
I would like to receive updates and information about Agilent products, services, and events. For full details of how Agilent will treat your information please click here to view our privacy policy. *
Yes
No
Email & Subscription Preferences *
Topic - Specific eNewslettersNew Product Announcements and Special Offers from our trusted life science partners
Future Lab Topics
Trends in Live Cell ImagingTrends in Protein ProductionTrends in ImmunodetectionEstablishing and Maintaining a Cell Culture FacilityTrends in Flow CytometryAutomation in Drug DiscoveryTrends in Next Gen SequencingTrends in COVID-19 R&DTrends in Genomic ScreeningTrends in GenomicsAntibody-Based TherapeuticsOptimizing workflows

By submitting this form, you consent to Biocompare storing your email address and contact information and transmitting your contact information to the Future Lab sponsor. You also agree to receive email from Biocompare and the sponsor. You may request to be removed at any time.